UCMC - Center for Clinical Cancer Genetics and Global Health — Chicago, Illinois

UCMC - Center for Clinical Cancer Genetics and Global Health is a clinical research site located in Chicago, Illinois, United States 60637.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

UCMC - Center for Clinical Cancer Genetics and Global Health has participated in 1 clinical trials.

Therapeutic areas: Celiac Disease, Celiac, Intestinal Disease.

Sponsors: ImmusanT, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCMC - Center for Clinical Cancer Genetics and Global Health?

UCMC - Center for Clinical Cancer Genetics and Global Health has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCMC - Center for Clinical Cancer Genetics and Global Health conducted?

UCMC - Center for Clinical Cancer Genetics and Global Health has 1 clinical trials on record. Their work covers Celiac Disease, Celiac, Intestinal Disease.

Is UCMC - Center for Clinical Cancer Genetics and Global Health accredited by Crixeo Clinical Trials?

UCMC - Center for Clinical Cancer Genetics and Global Health has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCMC - Center for Clinical Cancer Genetics and Global Health?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.